Inici › Sarcoma de teixit tou › Massachusetts › Boston
Assaigs clínics de Sarcoma de teixit tou a Boston, MA
18 estudis de Sarcoma de teixit tou busquen participants en centres de Boston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Distance-Based Exercise to Preserve Function and Prevent Disability
Reclutant
- Dana-Farber Cancer Institute, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
ReclutantFase 2
- Dana-Farber Cancer Institute - Oncology Department, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
ReclutantFase 1/2
- Dana Farber Cancer Institute., Boston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
ReclutantFase 1
- Dana-Farber Cancer Institute, Boston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
ReclutantFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
ReclutantFase 1
- Dana-Farber Cancer Institute, Boston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
ReclutantFase 1
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
Reclutant
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
Reclutant
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
ReclutantFase 1/2
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
ReclutantFase 1/2
- Dana Farber Cancer Institute, Boston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
ReclutantEstudi observacional
- Brigham and Women's Hospital, Boston
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
ReclutantEstudi observacional
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
ReclutantFase 1/2
- Massachusetts General Hospital,, Boston
Video Education With Result Dependent dIsclosure
Reclutant
- Dana Farber Cancer Institute, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
ReclutantFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
ReclutantFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
REtroperitoneal SArcoma Registry: an International Prospective Initiative
ReclutantEstudi observacional
- Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
Assaigs de Sarcoma de teixit tou en altres ciutats
- Houston, TX32 estudis
- New York City, NY19 estudis
- St. Louis, MO14 estudis
- Los Angeles, CA13 estudis
- Columbus, OH13 estudis
- Washington, DC12 estudis
- Memphis, TN11 estudis
- Philadelphia, PA10 estudis
- Rochester, MN9 estudis
- Nashville, TN9 estudis
- Aurora, CO9 estudis
- Queens, NY9 estudis
Altres estudis a Boston
- Càncer de mama111 estudis
- Càncer de pulmó de cèl·lules no petites90 estudis
- Càncer (tots els tipus)86 estudis
- Càncer colorrectal63 estudis
- Càncer metastàtic63 estudis
- Càncer de pulmó62 estudis
- Càncer d'ovari61 estudis
- Càncer de pròstata59 estudis
- Depressió52 estudis
- Càncer d'endometri50 estudis
- Insuficiència cardíaca44 estudis
- Leucèmia mieloide aguda44 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.